Source - LSE Regulatory
RNS Number : 9618X
Instem plc
11 January 2022
 

Instem plc

 ("Instem", the "Group" or the "Company")

 

Appointment of Stifel as Joint Broker

 

Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, announces the appointment of Stifel Nicolaus Europe Limited ("Stifel") as the Company's joint broker with immediate effect.

 

Stifel will work alongside Instem's existing broker, Singer Capital Markets, as the Company focuses on further increasing liquidity and engagement with US-based institutional investors.

 

For further information, please contact:

Instem plc

Via Walbrook

Phil Reason, CEO


Nigel Goldsmith, CFO




Singer Capital Markets (Nominated Adviser & Joint Broker)

+44 (0) 20 7496 3000

Peter Steel
Alex Bond
Rachel Hayes




Stifel Nicolaus Europe Limited (Joint Broker)

+44 (0)20 7710 7600

Ben Maddison


Alex Price




Walbrook Financial PR

+44 (0) 20 7933 8780

Tom Cooper

instem@walbrookpr.com

Nick Rome


Nicholas Johnson


 

About Instem

Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management Regulatory Submissions, Clinical Trial Acceleration, and Informatics-based Insight Generation.

 

Instem solutions are in use by over 700 customers worldwide, including all the largest 25 pharmaceutical companies, enabling clients to bring life enhancing products to market faster. Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.

 

Instem products and services address aspects of the entire drug development value chain, from discovery through to market launch. Management estimate that over 50% of all drugs on the market have been through some part of Instem's platform at some stage of their development.

 

To learn more about Instem solutions and its mission, please visit  www.instem.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPGZGMMFGFGZZM
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJBell logo

Related Charts